Metabolic Reset

Retatrutide + AICAR + MOTS-c — triple metabolic pathway activation across GLP-1, AMPK, and mitochondrial axes

Retatrutide is a GIP/GLP-1/glucagon triple agonist showing ~24% weight loss in Phase 2. AICAR is an AMPK activator that mimics exercise-induced metabolic adaptations (glucose uptake, fat oxidation). MOTS-c is a mitochondria-derived peptide that activates AMPK via the folate cycle, improving insulin sensitivity and endurance capacity. Three distinct metabolic nodes, one stack.

For research purposes only. Not for human consumption.